| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000259442.1 |
Ponatinib |
Brain lower grade glioma |
0.019028496 |
Resistant |
| ENSG00000259442.1 |
Ponatinib |
Colon adenocarcinoma |
0.030965571 |
Sensitive |
| ENSG00000259442.1 |
Ponatinib |
Stomach adenocarcinoma |
0.034118918 |
Sensitive |
| ENSG00000259442.1 |
Ponatinib |
Esophageal cancer |
0.032662036 |
Resistant |
| ENSG00000259442.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033162493 |
Resistant |
